Researchers at the University of Michigan Rogel Cancer Center and Michigan Medicine C.S. Mott Children's Hospital have demonstrated that a new liquid biopsy approach, which uses nanopore genetic sequencing technology, overcomes traditional barriers to quickly and efficiently diagnose and monitor high-grade pediatric gliomas. The nanopore system works by measuring changes in electrical current as biological molecules pass through tiny holes in a collection surface; different values correspond to different letters in the genetic code, thus allowing a DNA sequence to be read.
An official website of the United States government.